Human Endogenous Retrovirus K in Cancer: A Potential Biomarker and Immunotherapeutic Target

In diseases where epigenetic mechanisms are changed, such as cancer, many genes show altered gene expression and inhibited genes become activated. Human endogenous retrovirus type K (HERV-K) expression is usually inhibited in normal cells from healthy adults. In tumor cells, however, HERV-K mRNA exp...

Full description

Bibliographic Details
Main Authors: Gislaine Curty, Jez L. Marston, Miguel de Mulder Rougvie, Fabio E. Leal, Douglas F. Nixon, Marcelo A. Soares
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/12/7/726